Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2016-17
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2016-17
1. Annual Report
Annual Report
Torrent Pharma Inc
Torrent Do Brasil Ltd
Heumann Pharma GmbH
Heunet Pharma GmbH
Norispharm GmbH
Torrent Pharma GmbH
Torrent Pharma Philippines Inc.
Zao Torrent Pharma
Torrent Pharma S.R.L.
Torrent Pharma (UK) Ltd
Laboratorios Torrent, S.A. de C.V.
Laboratories Torrent Malaysia Sdn. Bhd.
Torrent Australasia Pty. Ltd
Torrent Pharma (Thailand) Co., Ltd.
Torrent Pharma France S.A.S
Aptil Pharma Limited
2. Intimation to Stock Exchange
Shareholding Pattern Q4
Shareholding Pattern Q3
Shareholding Pattern Q2
Shareholding Pattern Q1
Newspaper Notice of 44th AGM and E-voting procedure
Stock Exchange Intimation for 44th AGM
Intimation o Board Meeting for Results Dividend Book Closure 26th May, 2017
Newspaper Advertisement of Financial Results for Q4 2016-17
Post quarterly Financial Result Conference call with investors/analyst for quarter ended 31st March, 2017
News Clarification to Stock Exchanges_May 2017
Newspaper advertisement of BM notice - 26th May 2017
Intimation of Date of Board Meeting 26th May 2017 and Closure of Trading Window
Torrent Pharma acquires brands from Novartis AG
News Clarification to Stock Exchanges_April 2017
Newspaper advertisement of Financial results - 31st December, 2016
Intimation for Concall with Investors / Analysts- Q3 2016-17
Newspaper Advertisement Board Meeting 3rd Feb. 2017
Intimation for Boar d meeting and Interim Dividend 3rd Feb 2017
Intimation for Board Meeting Results and Press release 26th Oct. 2016
Intimation for Concall with Investors / Analysts- Q2 2016-17
Newspaper advertisement of BM notice for 26th October 2016
Newspaper advertisement of Financial results 27th July, 2016
Intimation for Results 27th July, 2016
Intimation for Concall with Investors 27th July 2016
3. Quarterly Results
Q1 16-17
Q2 16-17
Q3 16-17
Q4 16-17
Press Release on Q1 Results
Revenue Update
Q1, FY 2017 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q2 Results
Q2, FY 2017 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q3 Results
Revenue Update
Q3, FY 2017 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Revenue Update
Q4, FY 2017 Con call Transcript
Stand Alone Results
Consolidated Results
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>
